We will provide comprehensive project controls, engineering oversight and owner’s representation for the NextGen MURR (University of Missouri Research Reactor) project. As a key partner to the university, we will provide support through the design and licensing phase of building a new research reactor that will expand capacity to provide lifesaving radioisotopes used to diagnose and treat cancer.
Our team’s scope includes owner’s engineering support, facility design oversight, project management office development, and program management services. We will review the design and licensing deliverables from the NextGen MURR Consortium, which comprises Hyundai Engineering America, the Korea Atomic Energy Research Institute (KAERI), the Hyundai Engineering Co. and MPR Associates.
We will also monitor project schedule and budget performance, evaluate risk and assist the project team in preparing for regulatory milestones. BWX Technologies (BWXT) will support owner's engineer oversight for the reactor design.
This project builds on the existing MURR, which for decades has been the only U.S. producer of multiple medical isotopes used in lifesaving treatments and theranostics for more than a dozen types of cancer. Once complete, the 20-megawatt NextGen MURR will secure a reliable domestic supply of these critical medical resources. It will serve as an innovation and manufacturing hub for nuclear science, medicine and engineering in the United States for generations.